Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Pfizer-Allergan Leadership: Two Dealmakers In The Driver's Seat

This article was originally published in Scrip

Executive Summary

Ian Read will remain CEO of Pfizer Inc. when it mergers with Allergan PLC through a $160bn transaction set to close during the second half of 2016, but Allergan's like-minded CEO Brent Saunders will be sitting beside him as Pfizer PLC's president and chief operating officer – raising questions of whether Saunders is being positioned as Read's eventual replacement.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register